SCHEMBL28499992

SCHEMBL28499992

CN(C(=O)c1ccc(B2OC(C)(C)C(C)(C)O2)cc1)[C@H]1CC[C@](C)(O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.43
CA1 P00915 4/20 0.40
CA2 P00918 4/20 0.40
CA9 Q16790 4/20 0.40
P4HB P07237 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALOX5 P09917 1/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
ALDH1A1 P00352 2/20 0.37
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
ALOX15 P16050 1/20 0.36
LPL P06858 2/20 0.36
LIPG Q9Y5X9 2/20 0.36
PDK2 Q15119 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28906215 1.00 HSD11B1 (0.43) HSD11B1CA1CA2CA9P4HB
SCHEMBL28499994 1.00 HSD11B1 (0.43) HSD11B1CA1CA2CA9P4HB
SCHEMBL28511552 0.94 P4HB (0.42) CA1CA2CA9P4HBNPC1
SCHEMBL16625305 0.84 MCHR1 (0.43) ALDH1A1PDK2JAK2JAK1USP30
SCHEMBL16625313 0.81 HRH3 (0.47) NPC1RAB9AALDH1A1ALOX15PDK2
SCHEMBL16625306 0.81 MCHR1 (0.42) CA1CA2CA9P4HBALDH1A1
SCHEMBL16625307 0.80 MCHR1 (0.52) USP30
SCHEMBL28504623 0.79 HSD11B1 (0.48) HSD11B1NPC1RAB9AMEN1KMT2A
SCHEMBL28504621 0.79 HSD11B1 (0.48) HSD11B1NPC1RAB9AMEN1KMT2A
SCHEMBL28513974 0.79 HSD11B1 (0.48) HSD11B1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed